These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 820521)

  • 1. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
    Canada AT; Little AH; Creighton EL
    Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
    [No Abstract]   [Full Text] [Related]  

  • 2. The bioavailability of enteric-coated acetylsalicylic acid: a comparative study in reheumatoid arthritis, I.
    Canada AT; Little AH
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):727-32. PubMed ID: 812651
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind comparison of piroxicam and enteric coated ASA in rheumatoid arthritis. A Cooperative Multicenter Canadian trial.
    J Rheumatol; 1985 Feb; 12(1):68-77. PubMed ID: 3884806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 9. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
    Montgomery PR; Sitar DS
    Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood salicylate levels and clinical trials with a new form of enteric-coated aspirin: studies in rheumatoid arthritis and degenerative joint disease.
    Baum J
    J Clin Pharmacol J New Drugs; 1970; 10(2):132-7. PubMed ID: 4906542
    [No Abstract]   [Full Text] [Related]  

  • 15. [Salicylate dosage for children with juvenile chronic arthritis].
    Mäkelä AL; Yrjänä T
    Duodecim; 1978; 94(12):771-9. PubMed ID: 357138
    [No Abstract]   [Full Text] [Related]  

  • 16. Enteric coated aspirin today.
    Baum J
    J Rheumatol; 1985 Oct; 12(5):829-32. PubMed ID: 4087264
    [No Abstract]   [Full Text] [Related]  

  • 17. The absorption of Safapryn in patients with arthritis.
    Haslock I; Omar AS; Wright V
    Br J Clin Pract; 1976 Apr; 30(4):89-91. PubMed ID: 1268023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimentations with a buffered compound of acetylcsalycilic acid in rheumatoid arthritis].
    Liso V; Troccoli G
    Reumatismo; 1968; 20(4):273-8. PubMed ID: 5738055
    [No Abstract]   [Full Text] [Related]  

  • 19. The dosage effect of enteric-coated ASA on serum salicylate levels.
    Woodbury JF; Ahmad S
    N S Med Bull; 1973 Jun; 52(3):123-6. PubMed ID: 4584430
    [No Abstract]   [Full Text] [Related]  

  • 20. Enteric-coated aspirin in rheumatoid arthritis.
    Bird HA; Rhind V; Leatham P; Saunders A; Wright V
    Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.